Shekhar Gupta – D2L Pharma Research Solutions Private Limited
View Detailed Executive Profile →Professional Overview
- Shekhar Gupta is a co-founder of D2L Pharma Research Solutions Private Limited, which was established in July 2007.
- D2L Pharma focuses on providing innovative solutions in the pharmaceutical research sector, enhancing drug development processes.
- The organization has made significant strides in clinical research, contributing to improved methodologies and outcomes in pharmaceutical studies.
- Under Gupta's leadership, D2L Pharma has faced market challenges while successfully maintaining a reputation for high-quality services.
- D2L Pharma has collaborated with various pharmaceutical companies, facilitating successful clinical trials and research initiatives.
- Gupta has played a pivotal role in building a skilled team, ensuring that the organization is equipped with the expertise required to meet industry demands.
- The company has achieved several milestones, including regulatory approvals for clinical studies and successful project completions.
- D2L Pharma has influenced the landscape of pharmaceutical research solutions by adopting advanced technologies and methodologies.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| D2L Pharma Research Solutions Private Limited | Co-Founder | Jul 2007 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via D2L Pharma Research Solutions Private Limited corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Shekhar Gupta's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through D2L Pharma Research Solutions Private Limited's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)